Identification of a gene signature in cell cycle pathway for breast cancer prognosis using gene expression profiling data

Por Liu, Jiangang, Campen, Andrew, Huang, Shuguang, Peng, Sheng-Bin, Ye, Xiang, Palakal, Mathew, Dunker, A Keith, Xia, Yuni, Li, Shuyu
Publicado em 2008

Reactivation of Mitogen-activated Protein Kinase (MAPK) Pathway by FGF Receptor 3 (FGFR3)/Ras Mediates Resistance to Vemurafenib in Human B-RAF V600E Mutant Melanoma

Por Yadav, Vipin, Zhang, Xiaoyi, Liu, Jiangang, Estrem, Shawn, Li, Shuyu, Gong, Xue-Qian, Buchanan, Sean, Henry, James R., Starling, James J., Peng, Sheng-Bin
Publicado em 2012

Biochemical Characterization of Signal Peptidase I from Gram-Positive Streptococcus pneumoniae

Por Peng, Sheng-Bin, Wang, Li, Moomaw, John, Peery, Robert B., Sun, Pei-Ming, Johnson, Robert B., Lu, Jin, Treadway, Patti, Skatrud, Paul L., Wang, Q. May
Publicado em 2001

Distinct mobilization of leukocytes and hematopoietic stem cells by CXCR4 peptide antagonist LY2510924 and monoclonal antibody LY2624587

Por Peng, Sheng-Bin, Van Horn, Robert D., Yin, Tinggui, Brown, Robin M., Roell, William C., Obungu, Victor H., Ruegg, Charles, Wroblewski, Victor J., Raddad, Eyas, Stille, John R.
Publicado no Oncotarget (2017)

LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer

Por Vakana, Eliza, Pratt, Susan, Blosser, Wayne, Dowless, Michele, Simpson, Nicholas, Yuan, Xiu-Juan, Jaken, Susan, Manro, Jason, Stephens, Jennifer, Zhang, Youyan, Huber, Lysiane, Peng, Sheng-Bin, Stancato, Louis F.
Publicado no Oncotarget (2016)

Inhibition of CXCR4 by LY2624587, a Fully Humanized Anti-CXCR4 Antibody Induces Apoptosis of Hematologic Malignancies

Por Peng, Sheng-Bin, Zhang, Xiaoyi, Paul, Donald, Kays, Lisa M., Ye, Ming, Vaillancourt, Peter, Dowless, Michele, Stancato, Louis F., Stewart, Julie, Uhlik, Mark T., Long, Haiyan, Chu, Shaoyou, Obungu, Victor H.
Publicado no PLoS One (2016)

Safety and Pharmacokinetics of CXCR4 Peptide Antagonist, LY2510924, in Combination with Durvalumab in Advanced Refractory Solid Tumors

Por O'Hara, Mark H., Messersmith, Wells, Kindler, Hedy, Zhang, Wei, Pitou, Celine, Szpurka, Anna M., Wang, Dan, Peng, Sheng-Bin, Vangerow, Burkhard, Khan, Anis A., Koneru, Mythili, Wang-Gillam, Andrea
Publicado no J Pancreat Cancer (2020)

Identifying metastasis-initiating miRNA-target regulations of colorectal cancer from expressional changes in primary tumors

Por Lee, Jongmin, Hong, Hye Kyung, Peng, Sheng-Bin, Kim, Tae Won, Lee, Woo Yong, Yun, Seong Hyun, Kim, Hee Cheol, Liu, Jiangang, Ebert, Philip J., Aggarwal, Amit, Jung, Sungwon, Cho, Yong Beom
Publicado no Sci Rep (2020)

Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy

Por Cho, Byung-Sik, Zeng, Zhihong, Mu, Hong, Wang, Zhiqiang, McQueen, Teresa, Protopopova, Marina, Cortes, Jorge, Marszalek, Joseph R., Peng, Sheng-Bin, Ma, Wencai, Davis, R. Eric, Thornton, Donald E., Andreeff, Michael, Konopleva, Marina
Publicado no Blood (2015)

Chemical Proteomic Characterization of a Covalent KRASG12C Inhibitor

Por Wijeratne, Aruna, Xiao, Junpeng, Reutter, Christopher, Furness, Kelly W., Leon, Rebecca, Zia-Ebrahimi, Mohammad, Cavitt, Rachel N., Strelow, John M., Van Horn, Robert D., Peng, Sheng-Bin, Barda, David A., Engler, Thomas A., Chalmers, Michael J.
Publicado no ACS Med Chem Lett (2018)

Identification of Druggable Cancer Driver Genes Amplified across TCGA Datasets

Por Chen, Ying, McGee, Jeremy, Chen, Xianming, Doman, Thompson N., Gong, Xueqian, Zhang, Youyan, Hamm, Nicole, Ma, Xiwen, Higgs, Richard E., Bhagwat, Shripad V., Buchanan, Sean, Peng, Sheng-Bin, Staschke, Kirk A., Yadav, Vipin, Yue, Yong, Kouros-Mehr, Hosein
Publicado em 2014

Molecular dissection of CRC primary tumors and their matched liver metastases reveals critical role of immune microenvironment, EMT and angiogenesis in cancer metastasis

Por Liu, Jiangang, Cho, Yong Beom, Hong, Hye Kyung, Wu, Song, Ebert, Philip J., Bray, Steven M., Wong, Swee Seong, Ting, Jason C., Calley, John N., Whittington, Catherine F., Bhagwat, Shripad V., Reinhard, Christoph, Wild, Robert, Nam, Do-Hyun, Aggarwal, Amit, Lee, Woo Yong, Peng, Sheng-Bin
Publicado no Sci Rep (2020)

Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers

Por Ozkan-Dagliyan, Irem, Diehl, J. Nathaniel, George, Samuel D., Schaefer, Antje, Papke, Bjoern, Klotz-Noack, Kathleen, Waters, Andrew M., Goodwin, Craig M., Gautam, Prson, Pierobon, Mariaelena, Peng, Sen, Gilbert, Thomas S.K., Lin, Kevin H., Dagliyan, Onur, Wennerberg, Krister, Petricoin, Emanuel F., Tran, Nhan L., Bhagwat, Shripad V., Tiu, Ramon V., Peng, Sheng-Bin, Herring, Laura E., Graves, Lee M., Sers, Christine, Wood, Kris C., Cox, Adrienne D., Der, Channing J.
Publicado no Cell Rep (2020)